Marshall Wace’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $126M | Buy |
|
|||||
2025
Q1 | $888K | Sell |
|
|||||
2024
Q4 | $90.8M | Sell |
|
|||||
2024
Q3 | $141M | Buy |
|
|||||
2024
Q2 | $61.9M | Sell |
|
|||||
2024
Q1 | $193M | Buy |
|
|||||
2023
Q4 | $83M | Sell |
|
|||||
2023
Q3 | $86.6M | Sell |
|
|||||
2023
Q2 | $103M | Buy |
|
|||||
2023
Q1 | $74.6M | Buy |
|
|||||
2022
Q4 | $7M | Buy |
|
|||||
2022
Q3 | $2.83M | Sell |
|
|||||
2022
Q2 | $30.8M | Buy |
|
|||||
2022
Q1 | $2.7M | Sell |
|
|||||
2021
Q4 | $81.5M | Buy |
|
|||||
2021
Q3 | $62.9M | Buy |
|
|||||
2021
Q2 | $40.5M | Buy |
|
|||||
2021
Q1 | $8.55M | Buy |
|
|||||
2020
Q4 | $1.27M | Buy |
|
|||||
2020
Q3 | – | Sell |
|
|||||
2020
Q2 | $8.28M | Buy |
|
|||||
2020
Q1 | – | Sell |
|
|||||
2019
Q4 | $9.87M | Buy |
|
|||||
2019
Q3 | $2.45M | Sell |
|
|||||
2019
Q2 | $37.9M | Buy |
|
|||||
2019
Q1 | – | Sell |
|
|||||
2018
Q4 | $487K | Buy |
|
|||||
2018
Q3 | – | Sell |
|
|||||
2018
Q2 | $3M | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $9.82M | Buy |
|
|||||
2016
Q3 | $3.88M | Sell |
|
|||||
2016
Q2 | $7.3M | Buy |
|
|||||
2016
Q1 | $4.76M | Buy |
|
|||||
2015
Q4 | $322K | Sell |
|
|||||
2015
Q3 | $7.03M | Buy |
|
|||||
2015
Q2 | – | Sell |
|
|||||
2015
Q1 | $292K | Buy |
|
|||||
2014
Q4 | – | Sell |
|
|||||
2014
Q3 | $13.2M | Buy |
|
|||||
2014
Q2 | $4.19M | Buy |
|